Immunotherapy in renal cell carcinoma: latest evidence and clinical implications

Advances in understanding the mechanisms of tumour-induced immunosuppression have led to the development of immune-checkpoint inhibitors in cancer patients, including those with renal cell carcinoma (RCC). The optimal combination between immunotherapy and targeted agents (as well as the possible fav...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drugs Context
Autori principali: Santoni, Matteo, Massari, Francesco, Di Nunno, Vincenzo, Conti, Alessandro, Cimadamore, Alessia, Scarpelli, Marina, Montironi, Rodolfo, Cheng, Liang, Battelli, Nicola, Lopez-Beltran, Antonio
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioExcel Publishing Ltd 2018
Soggetti:
Editorial
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992965/
https://ncbi.nlm.nih.gov/pubmed/29899754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212528
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi